CONTEXT: Huntington's disease (HD) is a fatal hereditary neurodegenerative disorder characterized by motor, cognitive, and behavioral disturbances. Hypothalamic-pituitary-adrenal (HPA) axis dysfunction could contribute to a number of HD signs and symptoms; however, no data are available on cortisol diurnal variations and secretory dynamics in HD patients. OBJECTIVE: The aim of the study was to perform a detailed analysis of HPA axis function in HD patients in relation to clinical signs and symptoms. DESIGN, SETTING, AND PARTICIPANTS: Twenty-four-hour cortisol secretion was studied in eight early-stage, medication-free HD patients and eight age-, sex-, and body mass index-matched controls in a clinical research laboratory. Cortisol levels were measured every 10 min. MAIN OUTCOME MEASURES: Multiparameter autodeconvolution and cosinor regression were applied to quantify basal, pulsatile, and total cortisol secretion rates as well as diurnal variations in cortisol levels. RESULTS: Total cortisol secretion rate and the amplitude of the diurnal cortisol profile were both significantly higher in HD patients compared with controls (3490 +/- 320 vs. 2500 +/- 220 nmol/liter/24 h, P = 0.023; and 111 +/- 14 vs. 64 +/- 8 nmol/liter, P = 0.012, respectively). Cortisol concentrations in patients were particularly increased in the morning and early afternoon period. In HD patients, mean 24-h cortisol levels significantly correlated with total motor score, total functional capacity, as well as body mass index. CONCLUSIONS: HPA axis hyperactivity is an early feature of HD and is likely to result from a disturbed central glucocorticoid feedback due to hypothalamic pathology. HPA axis dysfunction may contribute to some signs and symptoms in HD patients.
CONTEXT: Huntington's disease (HD) is a fatal hereditary neurodegenerative disorder characterized by motor, cognitive, and behavioral disturbances. Hypothalamic-pituitary-adrenal (HPA) axis dysfunction could contribute to a number of HD signs and symptoms; however, no data are available on cortisol diurnal variations and secretory dynamics in HDpatients. OBJECTIVE: The aim of the study was to perform a detailed analysis of HPA axis function in HDpatients in relation to clinical signs and symptoms. DESIGN, SETTING, AND PARTICIPANTS: Twenty-four-hour cortisol secretion was studied in eight early-stage, medication-free HDpatients and eight age-, sex-, and body mass index-matched controls in a clinical research laboratory. Cortisol levels were measured every 10 min. MAIN OUTCOME MEASURES: Multiparameter autodeconvolution and cosinor regression were applied to quantify basal, pulsatile, and total cortisol secretion rates as well as diurnal variations in cortisol levels. RESULTS: Total cortisol secretion rate and the amplitude of the diurnal cortisol profile were both significantly higher in HDpatients compared with controls (3490 +/- 320 vs. 2500 +/- 220 nmol/liter/24 h, P = 0.023; and 111 +/- 14 vs. 64 +/- 8 nmol/liter, P = 0.012, respectively). Cortisol concentrations in patients were particularly increased in the morning and early afternoon period. In HDpatients, mean 24-h cortisol levels significantly correlated with total motor score, total functional capacity, as well as body mass index. CONCLUSIONS:HPA axis hyperactivity is an early feature of HD and is likely to result from a disturbed central glucocorticoid feedback due to hypothalamic pathology. HPA axis dysfunction may contribute to some signs and symptoms in HDpatients.
Authors: Jessica Raper; Steven Bosinger; Zachary Johnson; Gregory Tharp; Sean P Moran; Anthony W S Chan Journal: Brain Behav Immun Date: 2016-07-07 Impact factor: 7.217
Authors: Ye Zhang; Rong Ren; Linghui Yang; Junying Zhou; Yun Li; Jie Shi; Lin Lu; Larry D Sanford; Xiangdong Tang Journal: Sleep Date: 2019-10-09 Impact factor: 5.849
Authors: Charlotte Soneson; Magnus Fontes; Yongxia Zhou; Vladimir Denisov; Jane S Paulsen; Deniz Kirik; Asa Petersén Journal: Neurobiol Dis Date: 2010-08-02 Impact factor: 5.996
Authors: N Ahmad Aziz; Hanno Pijl; Marijke Frölich; Janny P Schröder-van der Elst; Chris van der Bent; Ferdinand Roelfsema; Raymund A C Roos Journal: J Neurol Date: 2009-12 Impact factor: 4.849
Authors: Carlos Cepeda; Damian M Cummings; Véronique M André; Sandra M Holley; Michael S Levine Journal: ASN Neuro Date: 2010-04-07 Impact factor: 4.146